Buy MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG TENOFOVIR DISOPROXIL FUMARATE

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG tablets combine emtricitabine and tenofovir disoproxil fumarate for HIV treatment. This oral medication is designed to help manage HIV infection by reducing viral load. Learn more about this antiretroviral therapy.

Strength

300 MG

Pack Size

Manufacturer / TM Owner

MYLAN PHARMACEUTICALS ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG tablets are used in the treatment of HIV infection. This combination medication is intended to reduce the amount of HIV in the body, helping to improve immune function and lower the risk of HIV-related complications. It is often used as part of a broader antiretroviral therapy regimen.

Side Effects

Common effects of MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG tablets may include nausea, diarrhea, and headache. Some individuals may also experience dizziness or fatigue. These effects can vary and are not experienced by everyone taking the medication.

Precautions & Warnings

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG tablets should be handled with care. It is important to follow the advice of a healthcare provider regarding the use of this medication. Individuals with kidney problems should discuss their condition with a healthcare provider before starting this treatment.

Avoid Interactions

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG tablets may interact with other medications, including those used to treat HIV, hepatitis B, and other infections. Alcohol and certain over-the-counter medications may also interact with this medication. Always inform your healthcare provider about all medications you are taking.

References

Frequently Asked Questions

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG tablets are used to treat HIV infection as part of a combination antiretroviral therapy regimen.

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG tablets are taken orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include nausea, diarrhea, headache, dizziness, and fatigue. These effects can vary and are not experienced by everyone.

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG may interact with other medications. Always inform your healthcare provider about all medications you are taking.

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300 MG may not be suitable for everyone, especially those with kidney problems. Consult a healthcare provider for personalized advice.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.